Hacı Ahmet KASAPKARA, Murat BİLGİN, Ekrem YETER, Uğur ARSLANTAŞ, Sadık AÇIKEL, Tolga ÇİMEN, Mehmet DOĞAN

İzole Koroner Arter Ektazisi ile Nötrofil - Lenfosit Oranı İlişkisi

Amaç: Nötrofil - lenfosit oranı (NLO) diğer pahalı inflamasyon göstergelerinin aksine basit, ucuz ve kolay ulaşılabilirbir göstergedir. Bu çalışmada koroner arter ektazisi(KAE) olan popülasyonda NLOyu inceledik Gereç ve Yöntemler: 2008-2012 yılları arasında hastanemizde yapılan 8250 koroner anjiyografinin (KAG) retros- pektif olarak taranması ile izole KAE olan 64 hasta ile görsel olarak normal koroner arterler saptanan 62 hasta çalış- maya dahil edilmiştir. Hastaların KAG öncesi bakılan kan örneklerinde NLOları karşılaştırıldı. Bulgular: Çalışma grupları arasında yaş, cinsiyet, hipertansiyon, diabetes mellitus, aktif sigara içiciliği ve kullanılanilaçlar açısından anlamlı fark bulunmadı (p>0.05). NLO KAE grubunda koronerleri normal olan hasta grubuna göreanlamlı olarak yüksek bulundu (p=0.0001). Sonuç: KAE normal koroner hastalarına göre yüksek NLO düzeyleri ile birliktedir. Bu bulgu izole KAE hastalarındaNLOnun basit, kolay ulaşılabilir bir inflamasyon göstergesi olarak kullanılabileceğini göstermektedir.

The Relationship Between Neutrophil to Lymphocyte Ratio and Isolated Coronary Artery Ectasia

Aim: Neutrophil to lymphocite ration (NLR) is cheap and feasible indicator of inflammation. In this study, we aimedto investigate to the realtionship between NLR and coronary artery ectasia (CAE). Material And Methods: 64 patients with CAE and 62 patients with normal coronary arteries were selected among 8250 coronary angiogrphies performed between 2008 and 2012. NLR of both groups were compared from blood samples drawn prior to coronary angiography. Results: No significant between groups with regard to sex, age, hypertension, smoking and drugs (p>0.005). NLR was significantly higher in CAE group (p=0.001). Conclusion: NLO was found to be higher in CAE. This finding supports the inflammatory status of CAE.

PDF

___

1. Swanton RH, Thomas ML, Coltart DJ, Jenkins BS, Webb-Peploe MM, Williams BT. Coronary artery ectasia--a variant of occlusive coronary arteriosclerosis. Br Heart J, 1978. 40(4): 393-400.
2. Falsetti HL, Carrol RJ. Coronary artery aneurysm. A review of the literature with a report of 11 new cases. Chest, 1976. 69(5): 630-6.
3. Befeler B, Aranda MJ, Embi A, Mullin FL, El-Sherif N, Lazzara R, Coronary artery aneurysms: study of the etiology, clinical cour- se and effect on left ventricular function and prognosis. Am J Med, 1977. 62(4): 597-607
4. Kruger D, Stierle U, Herrmann G, Simon R, Sheikhzadeh A. Exercise-induced myocardial ischemia in isolated coronary artery ectasias and aneurysms ("dilated coronopathy"). J Am Coll Cardi- ol, 1999. 34(5): 1461-70
5. Swaye PS, Fisher LD, Litwin P, Vignola PA, Judkins MP, Kemp HG, et al. Aneurysmal coronary artery disease. Circulation, 1983. 67(1): 134-8
6. Seabra-Gomes R, Somerville J, Ross DN, Emanuel R, Parker DJ, Wong M, Congenital coronary artery aneurysms. Br Heart J, 1974. 36(4): 329-35
7. Bjork VO, Bjork L. Intramural coronary artery aneurysm. A co- ronary artery steal syndrome. J Thorac Cardiovasc Surg, 1967. 54(1): 0-2
8. Vieweg WV, Alpert JS, Hagan AD. Caliber and distribution of nor- mal coronary arterial anatomy. Cathet Cardiovasc Diagn, 1976. 2(3): 269-80.
9. Sorrell VL, Davis MJ, Bove AA. Current knowledge and signifi- cance of coronary artery ectasia: a chronologic review of the lite- rature, recommendations for treatment, possible etiologies, and fu- ture considerations. Clin Cardiol, 1998. 21(3): 157-60.
10. Markis JE, Joffe CD, Cohn PF, Feen DJ, Herman MV, Gorlin R, Clinical significance of coronary arterial ectasia. Am J Cardiol, 1976. 37(2): 217-22.
11. Adiloglu AK, Can R, Nazli C, Ocal A, Ergene O, Tinaz G, et al. Ectasia and severe atherosclerosis: relationships with chlamydia pneumoniae, helicobacterpylori, and inflammatory markers. Tex Heart Inst J, 2005. 32(1): 21-7.
12. Yilmaz H, Tayyareci G, Sayar N, Gurkan U, Tangurek B, Asilturk R, et al. Plasma soluble adhesion molecule levels in coronary ar- tery ectasia. Cardiology, 2006. 105(3): 176-81.
13. Papadakis MC, Manginas A, Cotileas P, Demopoulos V, Voudris V, Pavlides G et al., Documentation of slow coronary flow by the TIMI frame count in patients with coronary ectasia. Am J Cardi- ol, 2001. 88(9): 1030-2.
14. Dogan A, Tuzun N, Turker Y, Akcay S, Kaya S, Ozaydin M. Mat- rix metalloproteinases and inflammatory markers in coronary ar- tery ectasia: their relationship to severity of coronary artery ecta- sia. Coron Artery Dis, 2008. 19(8): 559-63.
15. Li JJ, Nie SP, Qian XW, Zeng HS, Zhang CY. Chronic inflamma- tory status in patients with coronary artery ectasia. Cytokine, 2009. 46 (1): 61-4
16. Aydin M, Tekin IO, Dogan SM, Yildirim N, Arasli M, Sayin MR, et al., The levels of tumor necrosis factor-alpha and interleukin-6 in patients with isolated coronary artery ectasia. Mediators Inf- lamm, 2009. 2009: 106145.
17. Arbel Y, Finkelstein A, Halkin A, Birati EY, Revivo M, Zuzut M, et al., Neutrophil/lymphocyte ratio is related to the severity of co- ronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis, 2012. 225(2): 456-60.
18. Turak O, Ozcan F, Isleyen A, Tok D, Sokmen E, Buyukkaya E, et al., Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis. Am J Cardiol, 2012. 110(10): 1405-10.
19. Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocy- te ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol, 2008. 102(6): 653-7.
20. DeRouen TA, Murray JA, Owen W. Variability in the analysis of coronary arteriograms. Circulation, 1977. 55(2): 324-8
21. Pick RA, Glover MU, Vieweg WV. Myocardial infarction in a yo- ung woman with isolated coronary arteritis. Chest, 1982. 82(3): 378-80.
22. Tengiz I, Ercan E, Aliyev E, Sekuri C, Duman C, Altuglu I. Eleva- ted levels of matrix metalloprotein-3 in patients with coronary ane- urysm: A case control study. Curr Control Trials Cardiovasc Med, 2004. 5(1): 10.
23. Uyarel H, Okmen E, Tartan Z, Kasikcioglu H, Dayi SU, Karabulut A et al. The role of angiotensin converting enzyme genotype in co- ronary artery ectasia. Int Heart J, 2005. 46(1):.89-96. 24. Li JJ, Inflammation: an important mechanism for different clini- cal entities of coronary artery diseases. Chin Med J (Engl), 2005. 118 (21): 1817-26.
25. Turhan H, Yetkin E. Coronary artery ectasia: is it a destructive inf- lammatory lesion of the vascular wall? Int J Cardiol, 2007. 118(2): 241.
26. Kocaman SA Tacoy G, Sahinarslan A, Cengel A. Relationship bet- ween total and differential leukocyte counts and isolated coronary artery ectasia. Coron Artery Dis, 2008. 19(5): 307-10.
27. Meyer-Sabellek W. Brasch H. Atherosclerosis, inflammation, le- ukocyte function and the effect of statins. J Hypertens, 2006. 24(12): 2349-51.
28. Bian C, Wu Y, Shi Y, Xu G, Wang J, Xiang M et al. Predictive va- lue of the relative lymphocyte count in coronary heart disease. He- art Vessels, 2010. 25(6): 469-73.
29. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, et al. Which white blood cell subtypes predict increased cardiovas- cular risk? J Am Coll Cardiol, 2005. 45(10): 1638-43.
30. Ommen SR, Gibbons RJ, Hodge DO, Thomson SP. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol, 1997. 79 (6): 812-4.